MicroRNA-687 induced by hypoxia-inducible factor-1 targets phosphatase and tensin homolog in renal ischemia-reperfusion injury

Journal of the American Society of Nephrology

Volumn 26, Issue 7, 2015, Pages 1588-1596

  Bhatt, Kirti ^a,f   Wei, Qingqing ^a   Pabla, Navjotsingh ^a,g   Dong, Guie ^a   Mi, Qing Sheng ^b   Liang, Mingyu ^c   Mei, Changlin ^d   Dong, Zheng ^a,e  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b HENRY FORD HEALTH SYSTEM   (United States)

^c MEDICAL COLLEGE OF WISCONSIN   (United States)

^d SECOND MILITARY MEDICAL UNIVERSITY   (China)

^e CENTRAL SOUTH UNIVERSITY   (China)

^f CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^g ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1; MICRORNA; MICRORNA 687; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; UNCLASSIFIED DRUG; ACTIN BINDING PROTEIN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; PTEN PROTEIN, MOUSE; TENSINS;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL CYCLE PROGRESSION; CONTROLLED STUDY; GENE REPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; KIDNEY CELL; KIDNEY INJURY; KIDNEY ISCHEMIA; KIDNEY ISCHEMIA REPERFUSION INJURY; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RENAL PROTECTION; REPERFUSION INJURY; SIGNAL TRANSDUCTION; UPREGULATION; ANALYSIS OF VARIANCE; ANIMAL; C57BL MOUSE; DISEASE MODEL; GENETICS; KIDNEY DISEASE; METABOLISM; NORTHERN BLOTTING; PATHOPHYSIOLOGY; PROCEDURES; RANDOMIZATION;

ANALYSIS OF VARIANCE; ANIMALS; BLOTTING, NORTHERN; DISEASE MODELS, ANIMAL; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; KIDNEY DISEASES; MICE; MICE, INBRED C57BL; MICROFILAMENT PROTEINS; MICRORNAS; PTEN PHOSPHOHYDROLASE; RANDOM ALLOCATION; REAL-TIME POLYMERASE CHAIN REACTION; REPERFUSION INJURY; SIGNAL TRANSDUCTION; UP-REGULATION;

EID: 84934756768     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2014050463     Document Type: Article

References (67)

1. Mendell JT, Olson EN: MicroRNAs in stress signaling and human disease. Cell 148: 1172-1187, 2012
2. Ambros V: The functions of animalmicroRNAs.Nature 431: 350-355, 2004
3. BartelDP:MicroRNAs: target recognition and regulatory functions. Cell 136: 215-233, 2009
4. Harvey SJ, Jarad G, Cunningham J, Goldberg S, Schermer B, Harfe BD, McManusMT, Benzing T,Miner JH: Podocyte-specific deletion ofdicer alters cytoskeletal dynamics and causes glomerular disease. J Am Soc Nephrol 19: 2150-2158, 2008
5. Ho J, Ng KH, Rosen S, Dostal A, Gregory RI, Kreidberg JA: Podocytespecific loss of functional microRNAs leads to rapid glomerular and tubular injury. J Am Soc Nephrol 19: 2069-2075, 2008
6. Nagalakshmi VK, Ren Q, Pugh MM, Valerius MT, McMahon AP, Yu J: Dicer regulates the development of nephrogenic and ureteric compartments in the mammalian kidney. Kidney Int 79: 317-330, 2011
7. Patel V, Hajarnis S, Williams D, Hunter R, Huynh D, Igarashi P: Micro-RNAs regulate renal tubule maturation through modulation of Pkd1. J AmSoc Nephrol 23: 1941-1948, 2012
8. Sequeira-Lopez ML, Weatherford ET, Borges GR, Monteagudo MC, Pentz ES, Harfe BD, Carretero O, Sigmund CD, Gomez RA: The micro-RNA-processing enzyme dicer maintains juxtaglomerular cells. J AmSoc Nephrol 21: 460-467, 2010
9. Shi S, Yu L, Chiu C, Sun Y, Chen J, Khitrov G, Merkenschlager M, Holzman LB, Zhang W, Mundel P, Bottinger EP: Podocyte-selective deletion of dicer induces proteinuria and glomerulosclerosis. J AmSoc Nephrol 19: 2159-2169, 2008
10. Badal SS, Danesh FR: New insights into molecular mechanisms of diabetic kidney disease. Am J Kidney Dis 63[Suppl 2]: S63-S83, 2014
11. Bhatt K, Mi QS,Dong Z:microRNAs in kidneys: Biogenesis, regulation, and pathophysiological roles.AmJ Physiol Renal Physiol 300: F602-F610, 2011
12. Chandrasekaran K, Karolina DS, Sepramaniam S, Armugam A,Wintour EM, Bertram JF, Jeyaseelan K: Role of microRNAs in kidney homeostasis and disease. Kidney Int 81: 617-627, 2012
13. KatoM, Natarajan R:MicroRNA circuits in transforming growth factor-b actions and diabetic nephropathy. Semin Nephrol 32: 253-260, 2012
14. Li R, Chung AC, Yu X, Lan HY:MicroRNAs in diabetic kidney disease. Int J Endocrinol 2014: 593956, 2014
15. Lorenzen JM, Haller H, Thum T: MicroRNAs asmediators and therapeutic targets in chronic kidney disease. Nat Rev Nephrol 7: 286-294, 2011
16. Chung AC, Huang XR, Meng X, Lan HY: miR-192 mediates TGF-beta/ Smad3-driven renal fibrosis. J AmSoc Nephrol 21: 1317-1325, 2010
17. Kato M, Zhang J, Wang M, Lanting L, Yuan H, Rossi JJ, Natarajan R: MicroRNA-192 in diabetic kidney glomeruli and its function in TGFbeta-induced collagen expression via inhibition of E-box repressors. Proc Natl Acad Sci U S A 104: 3432-3437, 2007
18. Krupa A, Jenkins R, Luo DD, Lewis A, Phillips A, Fraser D: Loss of MicroRNA-192 promotes fibrogenesis in diabetic nephropathy. J AmSoc Nephrol 21: 438-447, 2010
19. Long J, Wang Y, Wang W, Chang BH, Danesh FR: MicroRNA-29c is a signature microRNA under high glucose conditions that targets Sprouty homolog 1, and its in vivo knockdown prevents progression of diabetic nephropathy. J Biol Chem286: 11837-11848, 2011
20. Eltzschig HK, Eckle T: Ischemia and reperfusion-from mechanism to translation. Nat Med 17: 1391-1401, 2011
21. LameireNH, Bagga A, Cruz D, DeMaeseneer J, Endre Z, Kellum JA, Liu KD, Mehta RL, Pannu N, Van Biesen W, Vanholder R: Acute kidney injury: An increasing global concern. Lancet 382: 170-179, 2013
22. Sharfuddin AA,Molitoris BA: Pathophysiology of ischemic acute kidney injury. Nat Rev Nephrol 7: 189-200, 2011
23. Bonventre JV, Yang L: Cellular pathophysiology of ischemic acute kidney injury. J Clin Invest 121: 4210-4221, 2011
24. KinseyGR,Okusa MD: Pathogenesis of acute kidney injury: Foundation for clinical practice. AmJ Kidney Dis 58: 291-301, 2011
25. Linkermann A, Chen G, Dong G, Kunzendorf U, Krautwald S, Dong Z: Regulated cell death in AKI [published online ahead of print June 12, 2014]. J Am Soc Nephrol doi: 10. 1681/ASN.2014030262
26. Godwin JG, Ge X, Stephan K, Jurisch A, Tullius SG, Iacomini J: Identification of a microRNA signature of renal ischemia reperfusion injury. Proc Natl Acad Sci U S A 107: 14339-14344, 2010
27. Kaucsar T, Revesz C, GodoM, Krenacs T, AlbertM, Szalay CI, Rosivall L, Benyo Z, Batkai S, ThumT, SzenasiG, Hamar P: Activation of the miR-17 family and miR-21 during murine kidney ischemia-reperfusion injury. Nucleic Acid Ther 23: 344-354, 2013
28. Saikumar J, Hoffmann D, Kim TM, Gonzalez VR, Zhang Q, Goering PL, Brown RP, Bijol V, Park PJ, Waikar SS, Vaidya VS: Expression, circulation, and excretion profile of microRNA-21,-155, and-18a following acute kidney injury. Toxicol Sci 129: 256-267, 2012
29. WeiQ, Bhatt K, He HZ, Mi QS, Haase VH, Dong Z: Targeted deletion of Dicer from proximal tubules protects against renal ischemia-reperfusion injury. J Am Soc Nephrol 21: 756-761, 2010
30. Xu X, Kriegel AJ, Liu Y, Usa K,Mladinov D, Liu H, Fang Y, Ding X, Liang M: Delayed ischemic preconditioning contributes to renal protection by upregulation of miR-21. Kidney Int 82: 1167-1175, 2012
31. Lorenzen JM, Kaucsar T, Schauerte C, Schmitt R, RongS,HubnerA, Scherf K, Fiedler J, Martino F, Kumarswamy R, Kolling M, Sorensen I, Hinz H, Heineke J, van Rooij E, Haller H, Thum T: MicroRNA-24 antagonism prevents renal ischemia reperfusion injury [published online ahead ofprint May 22, 2014]. J Am Soc Nephrol doi: 10. 1681/ASN.2013121329
32. Mineno J, Okamoto S, Ando T, Sato M, Chono H, Izu H, Takayama M, Asada K, Mirochnitchenko O, Inouye M, Kato I: The expression profile of microRNAs in mouse embryos. Nucleic Acids Res 34: 1765-1771, 2006
33. Rosenberger C,Mandriota S, Jürgensen JS,WiesenerMS,Hörstrup JH, Frei U, Ratcliffe PJ,Maxwell PH, Bachmann S, Eckardt KU: Expression of hypoxia-inducible factor-1alpha and-2alpha in hypoxic and ischemic rat kidneys. J Am Soc Nephrol 13: 1721-1732, 2002
34. Haase VH: Mechanisms of hypoxia responses in renal tissue. J AmSoc Nephrol 24: 537-541, 2013
35. Nangaku M, Eckardt KU: Hypoxia and the HIF systemin kidney disease. J Mol Med (Berl) 85: 1325-1330, 2007
36. Gunaratnam L, Bonventre JV: HIF in kidney disease and development. J Am Soc Nephrol 20: 1877-1887, 2009
37. Semenza GL: Oxygen sensing, hypoxia-inducible factors, and disease pathophysiology. Annu Rev Pathol 9: 47-71, 2014
38. Price PM, Safirstein RL, Megyesi J: The cell cycle and acute kidney injury. Kidney Int 76: 604-613, 2009
39. Yang L, Besschetnova TY, Brooks CR, Shah JV, Bonventre JV: Epithelial cell cycle arrest in G2/M mediates kidney fibrosis after injury. Nat Med 16: 535-543, 1p, 143, 2010
40. Song MS, Salmena L, Pandolfi PP: The functions and regulation of the PTEN tumour suppressor. Nat Rev Mol Cell Biol 13: 283-296, 2012
41. Chan SY, Loscalzo J: MicroRNA-210: A unique and pleiotropic hypoxamir. Cell Cycle 9: 1072-1083, 2010
42. el Azzouzi H, Leptidis S, Dirkx E, Hoeks J, van Bree B, Brand K, McClellan EA, Poels E, Sluimer JC, van den Hoogenhof MM, Armand AS, Yin X, Langley S, Bourajjaj M, Olieslagers S, Krishnan J, Vooijs M, Kurihara H, Stubbs A, Pinto YM, Krek W, Mayr M, da CostaMartins PA, Schrauwen P, De Windt LJ: The hypoxia-inducible microRNA cluster miR-199a;214 targets myocardial PPARd and impairs mitochondrial fatty acid oxidation. Cell Metab 18: 341-354, 2013
43. Cha ST, Chen PS, Johansson G, Chu CY, Wang MY, Jeng YM, Yu SL, Chen JS, Chang KJ, Jee SH, Tan CT, Lin MT, Kuo ML: MicroRNA-519c suppresses hypoxia-inducible factor-1alpha expression and tumor angiogenesis. Cancer Res 70: 2675-2685, 2010
44. Cascio S, D'Andrea A, Ferla R, Surmacz E, Gulotta E, Amodeo V, Bazan V, Gebbia N, Russo A: miR-20b modulates VEGF expression by targeting HIF-1 alpha and STAT3 in MCF-7 breast cancer cells. J Cell Physiol 224: 242-249, 2010
45. Taguchi A, Yanagisawa K, Tanaka M, Cao K, Matsuyama Y, Goto H, Takahashi T: Identification of hypoxia-inducible factor-1 alpha as a novel target for miR-17-92 microRNA cluster. Cancer Res 68: 5540-5545, 2008
46. Lei Z, Li B, Yang Z, Fang H, ZhangGM, Feng ZH,Huang B: Regulation of HIF-1alpha and VEGF by miR-20b tunes tumor cells to adapt to the alteration of oxygen concentration. PLoS ONE 4: e7629, 2009
47. Goda N, Dozier SJ, Johnson RS: HIF-1 in cell cycle regulation, apoptosis, and tumor progression. Antioxidants Redox Signal 5: 467-473, 2003
48. Goda N, Ryan HE, Khadivi B, McNulty W, Rickert RC, Johnson RS: Hypoxia-inducible factor 1alpha is essential for cell cycle arrest during hypoxia. Mol Cell Biol 23: 359-369, 2003
49. Carmeliet P, Dor Y, Herbert JM, Fukumura D, Brusselmans K, DewerchinM,NeemanM, Bono F, Abramovitch R, Maxwell P, Koch CJ, Ratcliffe P,Moons L, Jain RK, Collen D, Keshert E: Role of HIF-1alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis. Nature 394: 485-490, 1998
50. Koshiji M, Kageyama Y, Pete EA, Horikawa I, Barrett JC, Huang LE: HIF-1alpha induces cell cycle arrest by functionally counteractingMyc. EMBO J 23: 1949-1956, 2004
51. Takubo K, GodaN, YamadaW, Iriuchishima H, Ikeda E, Kubota Y, Shima H, Johnson RS, HiraoA, SuematsuM, Suda T: Regulation of the HIF-1alpha level is essential for hematopoietic stem cells. Cell Stem Cell 7: 391-402, 2010
52. Hackenbeck T, Knaup KX, Schietke R, Schödel J, Willam C, Wu X, Warnecke C, Eckardt KU, Wiesener MS: HIF-1 or HIF-2 induction is sufficient to achieve cell cycle arrest in NIH3T3 mouse fibroblasts independent from hypoxia. Cell Cycle 8: 1386-1395, 2009
53. Green SL, Freiberg RA, Giaccia AJ: p21(Cip1) and p27(Kip1) regulate cell cycle reentry after hypoxic stress but are not necessary for hypoxiainduced arrest.Mol Cell Biol 21: 1196-1206, 2001
54. Gardner LB, Li Q, Park MS, Flanagan WM, Semenza GL, Dang CV: Hypoxia inhibits G1/S transition through regulation of p27 expression. J Biol Chem 276: 7919-7926, 2001
55. KatoM, Putta S, WangM, Yuan H, Lanting L, Nair I, Gunn A, Nakagawa Y, Shimano H, Todorov I, Rossi JJ, Natarajan R: TGF-beta activates Akt kinase through a microRNA-dependent amplifying circuit targeting PTEN. Nat Cell Biol 11: 881-889, 2009
56. Dey N, Das F, Mariappan MM, Mandal CC, Ghosh-Choudhury N, Kasinath BS, Choudhury GG: MicroRNA-21 orchestrates high glucoseinduced signals to TOR complex 1, resulting in renal cell pathology in diabetes. J Biol Chem286: 25586-25603, 2011
57. Cai Z, Semenza GL: PTEN activity is modulated during ischemia and reperfusion: Involvement in the induction and decay of preconditioning. Circ Res 97: 1351-1359, 2005
58. Rappaport J, Hanss B, Kopp JB, Copeland TD, Bruggeman LA, Coffman TM, Klotman PE: Transport of phosphorothioate oligonucleotides in kidney: Implications for molecular therapy. Kidney Int 47: 1462-1469, 1995
59. Hamar P, Song E, Kökény G, Chen A, Ouyang N, Lieberman J: Small interfering RNA targeting Fas protects mice against renal ischemiareperfusion injury. Proc Natl Acad Sci U S A 101: 14883-14888, 2004
60. van de Water FM, Boerman OC, Wouterse AC, Peters JG, Russel FG, Masereeuw R: Intravenously administered short interfering RNA accumulates in the kidney and selectively suppresses gene function in renal proximal tubules. Drug Metab Dispos 34: 1393-1397, 2006
61. Molitoris BA, Dagher PC, Sandoval RM, Campos SB, Ashush H, Fridman E, Brafman A, Faerman A, Atkinson SJ, Thompson JD, Kalinski H, Skaliter R, Erlich S, Feinstein E: siRNA targeted to p53 attenuates ischemic and cisplatin-induced acute kidney injury. J Am Soc Nephrol 20: 1754-1764, 2009
62. Megyesi J, Andrade L, Vieira JM Jr, Safirstein RL, Price PM: Coordination of the cell cycle is an important determinant of the syndrome of acute renal failure. Am J Physiol Renal Physiol 283: F810-F816, 2002
63. Price PM, Safirstein RL, Megyesi J: Protection of renal cells from cisplatin toxicity by cell cycle inhibitors. Am J Physiol Renal Physiol 286: F378-F384, 2004
64. Wei Q, Dong Z: Mouse model of ischemic acute kidney injury: Technical notes and tricks. Am J Physiol Renal Physiol 303: F1487-F1494, 2012
65. Sinha D,Wang Z, Price VR, Schwartz JH, LieberthalW: Chemical anoxia of tubular cells induces activation of c-Src and its translocation to the zonula adherens. Am J Physiol Renal Physiol 284: F488-F497, 2003
66. Bhatt K, Zhou L, Mi QS, Huang S, She JX, Dong Z: MicroRNA-34a is induced via p53 during cisplatin nephrotoxicity and contributes to cell survival. Mol Med 16: 409-416, 2010
67. Silahtaroglu AN, Nolting D, Dyrskjøt L, Berezikov E, Møller M, Tommerup N, Kauppinen S: Detection of microRNAs in frozen tissue sections by fluorescence in situ hybridization using locked nucleic acid probes and tyramide signal amplification. Nat Protoc 2: 2520-2528, 2007